ad image

Pain Management

1 / 1
Startup Navega Therapeutics Aims to Develop a CRISPR Treatment for Pain
CRISPR

Startup Navega Therapeutics Aims to Develop a CRISPR Treatment for Pain

Emilie Branch

Pharma's Almanac

PAO-M09-19-NI-008Sep 04, 2019
Using a Scorpion Toxin to Study Pain and Inflammation
Pain Management

Using a Scorpion Toxin to Study Pain and Inflammation

Emilie Branch

Pharma's Almanac

PAO-M00-19-NI-002Sep 04, 2019
Heron Therapeutics, Inc.
Pain Management

Heron Announces European Medicines Agency Validation of Marketing Authorisation Application for HTX-011 for Postoperative Pain Management

Heron Therapeutics, Inc.

PR-M04-19-NI-026Apr 08, 2019
Late-Stage Positive Results Reported for Nerve Growth Factor Inhibitor
Clinical Trials

Late-Stage Positive Results Reported for Nerve Growth Factor Inhibitor

Nice Insight

PAO-M02-19-NI-017Feb 21, 2019
Talphera Inc.
FDA Approval

AcelRx Announces FDA Approval of DSUVIA™

Talphera Inc.

PR-M11-18-NI-017Nov 06, 2018
Grünenthal Group
Licensing Agreement

Grünenthal Acquires Global Rights for Qutenza®

Grünenthal Group

PR-M11-18-NI-020Nov 06, 2018
PainReform Ltd
Phase 3

PainReform Gets FDA Approval for Phase III Post-Operative Pain Relief Study

PainReform Ltd

PR-M07-18-NI-062Jul 19, 2018
Centrexion Therapeutics
Clinical Trials

Centrexion Therapeutics Raises $67 Million; Launching Phase 3 Program for CNTX-4975 in Knee Osteoarthritis Pain in 2018

Centrexion Therapeutics

PR-M01-18-NI-002Jan 02, 2018
SiteOne Therapeutics Garners US Department of Defense Award
Non-Opioid

SiteOne Therapeutics Garners US Department of Defense Award

Emilie Branch

Pharma's Almanac

PAO-M11-17-NI-036Nov 21, 2017
The Cost of Pain
Pain Management

The Cost of Pain

Guy Tiene

Nice Insight

PAO-M05-17-NI-027May 23, 2017
1 / 1